HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong
· Delayed Price · Currency is HKD 2.910
-0.040 (-1.36%)
May 20, 2025, 4:08 PM HKT
HighTide Therapeutics Statistics
Total Valuation
HKG:2511 has a market cap or net worth of HKD 1.52 billion. The enterprise value is 1.08 billion.
| Market Cap | 1.52B |
| Enterprise Value | 1.08B |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2511 has 514.77 million shares outstanding. The number of shares has increased by 74.08% in one year.
| Current Share Class | 514.77M |
| Shares Outstanding | 514.77M |
| Shares Change (YoY) | +74.08% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 2.79% |
| Owned by Institutions (%) | 0.02% |
| Float | 265.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.36 |
| P/TBV Ratio | 3.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.66 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.18.
| Current Ratio | 4.67 |
| Quick Ratio | 4.47 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -289.93 |
Financial Efficiency
Return on equity (ROE) is -67.76% and return on invested capital (ROIC) is -45.52%.
| Return on Equity (ROE) | -67.76% |
| Return on Assets (ROA) | -41.03% |
| Return on Invested Capital (ROIC) | -45.52% |
| Return on Capital Employed (ROCE) | -98.84% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -5.80M |
| Employee Count | 70 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -54.33% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 66.51 |
| Average Volume (20 Days) | 2,926,625 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -473.29M |
| Pretax Income | -406.00M |
| Net Income | -406.29M |
| EBITDA | -472.72M |
| EBIT | -473.29M |
| Earnings Per Share (EPS) | -0.90 |
Balance Sheet
The company has 522.00 million in cash and 82.90 million in debt, giving a net cash position of 439.10 million or 0.85 per share.
| Cash & Cash Equivalents | 522.00M |
| Total Debt | 82.90M |
| Net Cash | 439.10M |
| Net Cash Per Share | 0.85 |
| Equity (Book Value) | 451.39M |
| Book Value Per Share | 1.00 |
| Working Capital | 429.31M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:2511 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.08% |
| Shareholder Yield | -74.08% |
| Earnings Yield | -26.75% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |